Sculptor Capital LP Immunity Bio, Inc. Put Options Transaction History

Sculptor Capital LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$4.82 - $9.15 $228,468 - $433,710	-47,400 Reduced 17.81%	218,800 $1.38 Million
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $859,826 - $1.64 Million	266,200 New	266,200 $1.43 Million
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $125,613 - $526,261	82,100 Added 166.87%	131,300 $365,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $179,580 - $316,356	49,200 New	49,200 $245,000
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $774,165 - $1.15 Million	-153,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $64,368 - $107,520	-4,800 Reduced 3.04%	153,300 $2.19 Million
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $2.03 Million - $6.68 Million	158,100 New	158,100 $3.75 Million

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.07B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.